Exenatide and Tildrakizumab-asmn Subcutaneous
Determining the interaction of Exenatide and Tildrakizumab-asmn Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: exenatide
Brand name: Byetta Prefilled Pen, Bydureon, Bydureon BCise, Bydureon Pen, Bydureon Tray
Synonyms: n.a.
Generic Name: tildrakizumab
Brand name: Ilumya
Synonyms: Tildrakizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Exenatide-Tilia Fe
- Exenatide-Tiludronate
- Exenatide-Timentin
- Exenatide-Timentin Add-Vantage
- Exenatide-Timentin Injection
- Exenatide-Timentin Novaplus
- Tildrakizumab-asmn Subcutaneous-Exenatide extended release
- Tildrakizumab-asmn Subcutaneous-Exenatide Extended-Release Injection (Bydureon BCise)
- Tildrakizumab-asmn Subcutaneous-Exenatide Extended-Release Injection (Bydureon) (Pens)
- Tildrakizumab-asmn Subcutaneous-Exenatide Extended-Release Injection (Bydureon) (Trays)
- Tildrakizumab-asmn Subcutaneous-Exenatide Injection (Byetta)
- Tildrakizumab-asmn Subcutaneous-Exenatide Subcutaneous